Thank you, Glenn. Good morning, everyone. As of September 30, 2024, Primerica has successfully exited its senior health business by abandoning e-TeleQuote Inc and permanently surrendering and relinquishing our rights to e-TeleQuote. The segment's results are now reported in discontinued operations and its performance measures have been excluded from all periods presented. In my comments today, I will cover the earnings results for each of our core segments followed by a discussion of consolidated insurance and other operating expenses and an update on our capital position. Starting with the Term Life segment. Revenues of $450 million during the quarter increased 5% year-over-year, driven by 6% growth in adjusted direct premiums. Pre-tax income of $178 million rose 26% due in part to a $2 billion -- to a $28 million remeasurement gain recognized in the quarter. Under LDTI accounting rules, our Term Life margins are generally predictable given that they are not highly sensitive to last variances, while mortality variances are limited by our extensive use of reinsurance. When we make changes to the long-term actuarial assumptions, the segment's results can be subject to some volatility, as was the case in this quarter during our annual assumption review. As a reminder, our assumptions are set as best estimates and reflect our long-term view of the future that avoid forecasting short-term volatility. As we disclosed in our 2023 Form 10-K filed in February of this year, the disability incident rate under our waiver of premium rider has been falling since the pandemic. Unlike our mortality for lapse rates, which has had both favorable and unfavorable experience since 2020 and the disability incident rate has declined and remained at similar levels. We reflected an improvement in our best estimate assumptions and recognized a $27 million remeasurement gain in the current quarter. Because these waiver benefits are not debt benefits, it is not part of the YRT reinsurance program, which resulted in a disproportionate impact to our financial results. We also made slight adjustments to our lapse and mortality assumptions neither of which had a meaningful impact to our financial results. In aggregate, these updates resulted in a $1 million remeasurement gain net of reinsurance. Turning to Experian [ph] experiences. We observed higher lapses and lower mortality from our updated assumptions, which had an immaterial net impact in the remeasurement. We believe higher cost of living pressure on middle-income family remains a key contributor for elevated lapses across multiple durations. Persistency on policies issued over the last year remained largely in line with our assumptions. We expect the overall persistency to normalize over time. While higher lapses can constrain future ADP growth under LDTI lapses do not meaningfully impact our current key financial ratios. Looking at our key financial ratios, the remeasurement gain recorded in the current year period contributed a favorable 430 basis points to the benefits and claims ratio. Adjusting for this item, the benefits and claims ratio at 57.6% was largely in line with the prior year period. The debt amortization ratio at 11.9% and the insurance expense ratio at 7.4% remained consistent with the prior year period. Finally after adjusting for the impact of the remeasurement gain the revised operating margin of 23.1% was in line with the prior year period. In the fourth quarter, we expect the benefits and claims ratio to be around 58% the DAC amortization ratio to be around 12%, and an operating margin of around 22%. I will provide full year guidance for 2025 in February. Turning next to the results of our Investment and Savings Products segment, which continues to benefit from strong product demand across nearly all product lines and favorable equity market conditions. During the quarter, revenues of $266 million increased 22% due to a combination of strong sales benefiting from client demand and higher average client asset values. Pre-tax income of $80 million rose 24%. Revenue from sales-based commissions and fees of $96 million increased 32%, while revenue generating sales rose 29%. Revenues grew at a slightly higher rate than correlated sales due to continued strong demand for variable annuities. Sales-based commission expenses generally rose in line with correlated sales. Asset-based revenues of $142 million rose 19% in line with 18% increase in average client asset value, while associated commission expenses grew at a similar rate. The Corporate and Other Distributed Products segment incurred a pre-tax operating loss of $5.7 million during the third quarter compared to pre-tax operating income of $3.1 million in the prior year period. The current quarter included a $5.2 million remeasurement loss due to a refinement in assumptions on the subset of the closed book of non-term life insurance business. The segment continues to benefit from a combination of higher yielding investments and growth in size of the portfolio, which added $4 million to net investment income compared to the prior year period. Finally, adjusted consolidated insurance and other operating expenses were $145 million during the third quarter, up 13% year-over-year. The increase is primarily due to higher variable expenses, resulting from the growth in recruiting and licensing and rising sales and production in the ISP and Term Life segment, as well as higher employee-related costs due to the company's strong performance in 2024. As we look into the future, we expect fourth quarter insurance and other operating expenses to grow around 9% resulting in full year growth of 9% or approximately $50 million. Our projection is above our previous guidance, because of higher ISP client asset levels in 2024 and growth-related higher variable and employee costs. Moving to our capital position. The holding company had cash and invested assets of $383 million at the end of September, 2024. During the third quarter, we purchased $129 million of common stock. And since the end of third quarter, we completed our current authorized repurchase program of $425 million. As of September 30, 2024, Primerica Life estimated RBC ratio was 440%. With that, operator I'll open the line for questions.